The company is on high alert for competition from biosimilar products, which could be superior or more cost-effective, impacting market acceptance and revenue for its entire product portfolio. This highlights a need for competitive intelligence, market access, and commercial effectiveness strategies.
Filing excerpt
competing products and product candidates (including biosimilar products) that may be superior to, or more cost effective than, products marketed or otherwise commercialized by Regeneron and/or its collaborators or licensees
What this signalsFilings often name leadership changes, deals and spending plans.
Competitors
sec-10kcompetitorNamedGet every 10-K signal for Regeneron and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Regeneron this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/f4a1b954-d731-492a-999c-01e47850be38 returns this record as JSON. POST /v1/companies/enrich returns every signal for regeneron.com.
{
"signal_id": "f4a1b954-d731-492a-999c-01e47850be38",
"signal_type": "sec-10k",
"signal_subtype": "competitorNamed",
"detected_at": "2026-02-10T07:49:34.287+00:00",
"company": {
"name": "Regeneron",
"domain": "regeneron.com"
},
"data": {
"detail": "The company is on high alert for competition from biosimilar products, which could be superior or more cost-effective, impacting market acceptance and revenue for its entire product portfolio. This highlights a need for competitive intelligence, market access, and commercial effectiveness strategies.",
"summary": "Regeneron identifies cost-effective biosimilars as a primary risk to commercial success.",
"excerpts": "competing products and product candidates (including biosimilar products) that may be superior to, or more cost effective than, products marketed or otherwise commercialized by Regeneron and/or its collaborators or licensees",
"relevance": 0.8,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/regn-20251231.htm",
"filing_date": "2026-02-04",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Competitive intelligence",
"signal_category": "market",
"competitors_mentioned": [
"biosimilar products"
]
}
}
curl https://signals.autobound.ai/v1/signals/f4a1b954-d731-492a-999c-01e47850be38 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"regeneron.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.